Compugen Discusses Additions to Informatics Infrastructure Underlying its Drug Discovery Business | GenomeWeb

This week, Compugen provided details about an informatics platform it is developing internally for identifying protein functional interaction sites as part of its efforts to discover functional monoclonal antibodies in oncology and immunology that can be used as therapeutic candidates against the company's drug targets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.